Committees’ opinions on applications for authorisation available
The consolidated opinions of the Committees for Risk Assessment and Socio-economic Analysis are now available for:
- 14 uses of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated by
- Siemens Healthcare Diagnostics Products Ltd;
- Hospira Zagreb d.o.o., a Pfizer company;
- Merck KGaA;
- Rousselot bvba;
- Pfizer Manufacturing Belgium NV;
- DiaSorin S.p.A.;
- Siemens Healthcare Diagnostics Products GmbH (1, 2, 3, 4, 5);
- Roche Diagnostics GmbH (1, 2, 3)
- Four uses of 4-nonylphenol, branched and linear, ethoxylated by:
- Roche Diagnostics GmbH (1, 2, 3); and
- Abbott Diagnostics GmbH.